AR058571A1 - Procedimiento mejorado para la preparacion de sales de 4-(bencimidazolilmetilamino)-benzamidinas - Google Patents

Procedimiento mejorado para la preparacion de sales de 4-(bencimidazolilmetilamino)-benzamidinas

Info

Publication number
AR058571A1
AR058571A1 ARP060105633A ARP060105633A AR058571A1 AR 058571 A1 AR058571 A1 AR 058571A1 AR P060105633 A ARP060105633 A AR P060105633A AR P060105633 A ARP060105633 A AR P060105633A AR 058571 A1 AR058571 A1 AR 058571A1
Authority
AR
Argentina
Prior art keywords
preparation
benzamidinas
bencimidazolilmetilamino
salts
improved procedure
Prior art date
Application number
ARP060105633A
Other languages
English (en)
Spanish (es)
Inventor
Georg Zerban
Kerstin Schlarb
Gunter Koch
Bjoern Weyell
Heinz-Peter Schmitt
Rainer Hamm
Arndt Hausherr
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR058571A1 publication Critical patent/AR058571A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ARP060105633A 2005-12-21 2006-12-20 Procedimiento mejorado para la preparacion de sales de 4-(bencimidazolilmetilamino)-benzamidinas AR058571A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005061624A DE102005061624A1 (de) 2005-12-21 2005-12-21 Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen

Publications (1)

Publication Number Publication Date
AR058571A1 true AR058571A1 (es) 2008-02-13

Family

ID=37950582

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105633A AR058571A1 (es) 2005-12-21 2006-12-20 Procedimiento mejorado para la preparacion de sales de 4-(bencimidazolilmetilamino)-benzamidinas

Country Status (23)

Country Link
US (1) US7880016B2 (https=)
EP (1) EP1968949B1 (https=)
JP (1) JP5317702B2 (https=)
KR (1) KR101411961B1 (https=)
CN (1) CN101346355B (https=)
AR (1) AR058571A1 (https=)
AT (1) ATE485279T1 (https=)
AU (1) AU2006326980B2 (https=)
BR (1) BRPI0620150A2 (https=)
CA (1) CA2632310C (https=)
CY (1) CY1111113T1 (https=)
DE (2) DE102005061624A1 (https=)
DK (1) DK1968949T3 (https=)
ES (1) ES2355045T3 (https=)
IL (1) IL192242A (https=)
NZ (1) NZ569636A (https=)
PL (1) PL1968949T3 (https=)
PT (1) PT1968949E (https=)
RU (1) RU2425827C2 (https=)
SI (1) SI1968949T1 (https=)
TW (1) TWI411608B (https=)
WO (1) WO2007071743A1 (https=)
ZA (1) ZA200804198B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
DE10339862A1 (de) * 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
DE102006054005A1 (de) * 2006-11-16 2008-05-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
US7767589B2 (en) * 2007-02-07 2010-08-03 Raytheon Company Passivation layer for a circuit device and method of manufacture
US8173906B2 (en) * 2007-02-07 2012-05-08 Raytheon Company Environmental protection coating system and method
US20110129538A1 (en) * 2008-03-28 2011-06-02 Boehringer Ingelheim International Gmbh Process for preparing orally administered dabigatran formulations
AR072143A1 (es) * 2008-06-16 2010-08-11 Boehringer Ingelheim Int Procedimiento para la preparacion de un producto intermedio para la sintesis de etexilato de dabigatran
JP5642670B2 (ja) * 2008-06-16 2014-12-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランの合成の中間体の製造方法
JP2011527318A (ja) 2008-07-14 2011-10-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランを含有する医薬組成物の製造方法
AU2009315729A1 (en) 2008-11-11 2010-05-20 Boehringer Ingelheim International Gmbh Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
US8399678B2 (en) 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
JP2013521318A (ja) * 2010-03-08 2013-06-10 ラティオファルム ゲー・エム・ベー・ハー ダビガトランエテキシラートを含有する医薬組成物
US9006448B2 (en) * 2010-12-06 2015-04-14 Msn Laboratories Private Limited Process for the preparation of benzimidazole derivatives and its salts
EP2522662A1 (en) 2011-05-11 2012-11-14 Medichem, S.A. Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
WO2013150545A2 (en) * 2012-04-02 2013-10-10 Msn Laboratories Limited Process for the preparation of benzimidazole derivatives and salts thereof
EP2890692A1 (en) 2012-08-31 2015-07-08 Ranbaxy Laboratories Limited Process for the preparation of crystalline form i of methanesulfonate salt of dabigatran etexilate
US9399616B2 (en) 2012-10-22 2016-07-26 Boehringer Ingelheim International Gmbh Process for the manufacture of 4-aminobenzoamidine dihydrochloride
US10077251B2 (en) 2012-10-29 2018-09-18 Biophore India Pharmaceuticals Pvt. Ltd. Process for the synthesis of Dabigatran Etexilate and its intermediates
WO2014068587A2 (en) * 2012-10-29 2014-05-08 Biophore India Pharmaceuticals Pvt. Ltd. An improved process for the synthesis of dabigatran and its intermediates
CN103275065A (zh) * 2013-05-30 2013-09-04 上海同昌生物医药科技有限公司 一种新的生产达比加群酯的方法
EP2835370A1 (en) 2013-08-08 2015-02-11 Medichem, S.A. New crystals of dabigatran etexilate mesylate
US10112901B2 (en) 2014-07-03 2018-10-30 Shanghai Institute Of Pharmaceutical Industry Method for preparing dabigatran etexilate intermediate, and intermediate compound
CN105461686A (zh) * 2014-08-25 2016-04-06 江苏豪森药业股份有限公司 制备高纯度甲磺酸达比加群酯晶型的方法
CN104987323B (zh) * 2015-07-10 2017-08-22 浙江美诺华药物化学有限公司 一种达比加群酯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) * 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
PE121699A1 (es) * 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
DE19743435A1 (de) * 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
TWI248435B (en) * 1998-07-04 2006-02-01 Boehringer Ingelheim Pharma Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
US6248770B1 (en) * 1998-07-09 2001-06-19 Boehringer Ingelheim Pharma Kg Benzimidazoles having antithrombotic activity
DE19962329A1 (de) 1999-12-23 2001-06-28 Boehringer Ingelheim Pharma Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel
US6451832B2 (en) * 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
CA2476054C (en) * 2002-03-07 2011-11-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical composition for the oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino)-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino)-propionic acid ethyl ester and the salts thereof
NL1026498C2 (nl) * 2004-06-24 2005-12-28 Free Lift B V Hellinglifteenheid met blokkeerinrichting en blokkeerinrichting bestemd voor hellinglifteenheid.
EP1609784A1 (de) * 2004-06-25 2005-12-28 Boehringer Ingelheim Pharma GmbH & Co.KG Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen

Also Published As

Publication number Publication date
IL192242A0 (en) 2008-12-29
RU2425827C2 (ru) 2011-08-10
IL192242A (en) 2012-02-29
DE602006017743D1 (de) 2010-12-02
CA2632310A1 (en) 2007-06-28
ATE485279T1 (de) 2010-11-15
NZ569636A (en) 2010-04-30
TWI411608B (zh) 2013-10-11
CY1111113T1 (el) 2015-06-11
US7880016B2 (en) 2011-02-01
DE102005061624A1 (de) 2007-06-28
US20070185173A1 (en) 2007-08-09
ES2355045T3 (es) 2011-03-22
JP2009520766A (ja) 2009-05-28
TW200740791A (en) 2007-11-01
PT1968949E (pt) 2010-12-22
AU2006326980A1 (en) 2007-06-28
DK1968949T3 (da) 2011-01-24
CN101346355B (zh) 2012-09-05
EP1968949B1 (en) 2010-10-20
RU2008129637A (ru) 2010-01-27
WO2007071743A1 (en) 2007-06-28
JP5317702B2 (ja) 2013-10-16
BRPI0620150A2 (pt) 2011-11-01
EP1968949A1 (en) 2008-09-17
KR20080081179A (ko) 2008-09-08
KR101411961B1 (ko) 2014-06-27
SI1968949T1 (sl) 2011-02-28
PL1968949T3 (pl) 2011-04-29
CN101346355A (zh) 2009-01-14
CA2632310C (en) 2014-02-11
ZA200804198B (en) 2009-04-29
AU2006326980B2 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
AR058571A1 (es) Procedimiento mejorado para la preparacion de sales de 4-(bencimidazolilmetilamino)-benzamidinas
AR049410A1 (es) Procedimiento para la preparacion de una 4-(benzimidazolilmetilamino)-benzamidina
ES2634490T3 (es) Derivados de ácido napht-2-ylacetico para tratar el sida
AR065196A1 (es) Procedimiento para la preparacion de un derivado de bencimidazol
MX382401B (es) Microorganismos para la producción de feromonas de insectos y compuestos relacionados.
EA200900857A1 (ru) Замещённые 1-(3-пиридинил)пиразол-4-ил-уксусные кислоты, способ их получения и их применение в качестве гербицидов и регуляторов роста растений
MX2009006865A (es) Proceso para la preparacion de compuestos 6,6-dimetil-3-aza-bicicl o-[3.1.0]-hexano utilizando intermediario bisulfitico.
UA101036C2 (en) Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids
MX2016010312A (es) Produccion de productos de poliolefina.
PE20061142A1 (es) Forma cristalina gamma de clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que la contienen
NO20075555L (no) Fremgangsmate for fremstilling av fosfolipider
MX2010006183A (es) Procesos para producir acidos cicloalquilcarboxamido-piridin benzoicos.
UA108646C2 (xx) Клостридіальні токсини, що руйнуються
MX2016013160A (es) Marcas geneticas de transgenes y metodos de uso.
AR070357A1 (es) Producto para cuidado oral y metodos de uso y manufactura del mismo
AR076027A1 (es) Metodos e intermediarios para la preparacion de agentes farmaceuticos
MA40809B1 (fr) Procede de reparation d'amidon inhibe presentant une stabilite au stockage amelioree
MX378591B (es) Intermedios para la sintesis de derivados de acido biliar, en particular, de acido obeticolico
CR20110208A (es) Proceso para la preparación de benzonorbornenos
AR054735A1 (es) Proceso de obtencion de un derivado de piperazina
AR080325A1 (es) Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas
NO20075364L (no) Forbedringer i eller i forbindelse med bitumenmaterialer
Lee et al. Syntheses of resveratrol and its hydroxylated derivatives as radical scavenger and tyrosinase inhibitor
BR112014026474A2 (pt) método para produzir ácido 5-(difluorometil)pirazina-2-carboxílico e intermediário de produção do mesmo
UY33262A (es) Procedimiento para la preparacion de 2-(ciclohexilmetil)-n-{2-[(2s)-1-metilpirrolidin-2-il]etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida

Legal Events

Date Code Title Description
FA Abandonment or withdrawal